The Huberman Lab
The Huberman Lab

Therapy, Treating Trauma & Other Life Challenges | Dr. Paul Conti

My guest this episode is Dr. Paul Conti, M.D., a psychiatrist and expert in treating trauma, personality disorders and psychiatric illnesses and challenges of various kinds. Dr. Conti earned his MD at Stanford and did his residency at Harvard Medical School. He now runs the Pacific Premiere Group—a

Featured Speakers

Scicomm Media HostAndrew Huberman Guest

Topics Discussed

Episode Summary

Executive Summary: Andrew Huberman and Dr. Paul Conti discuss trauma as a brain-changing experience that overwhelms coping and reshapes mood, behavior, vigilance, and self-concept. They explore guilt, shame, repetition compulsion, self-therapy, choosing a therapist, and how medications and psychedelics can support healing when used thoughtfully. The episode emphasizes curiosity, compassion, and direct engagement with trauma rather than avoidance.

Main Topics: Defining trauma as brain change (Priority: 5/5): Trauma is framed not as any negative event, but as an experience that overwhelms coping capacity and leaves lasting changes in brain function, behavior, sleep, mood, and physical health. Guilt, shame, and avoidance (Priority: 5/5): The discussion explains why trauma often triggers guilt and shame, which then drive concealment, self-blame, and avoidance instead of direct processing. Repetition compulsion and maladaptive loops (Priority: 5/5): Conti argues that people often repeat abusive or harmful patterns in an unconscious attempt to resolve the original trauma and change the past. Therapy process and therapist selection (Priority: 4/5): They cover how to show up to therapy, how to know if it is working, and why rapport matters more than rigid modality labels when choosing a therapist. Self-therapy and low-cost tools (Priority: 4/5): Journaling, writing, talking to trusted others, and reflective observation are presented as accessible ways to create distance from trauma and gain insight. Medication, ADHD, and psychiatric prescribing (Priority: 4/5): Conti critiques overmedication driven by brief visits and argues that medications can be useful short-term or as adjuncts, but should not replace understanding root causes. Psychedelics and MDMA as therapeutic tools (Priority: 5/5): Psilocybin, LSD, and MDMA are discussed as powerful, clinically promising tools for trauma when used in structured, guided settings, with different mechanisms and risks.

Key Arguments: Trauma should be defined clinically as an event or process that overwhelms coping and changes how a person functions afterward, not merely as something unpleasant. Guilt and shame are evolutionarily adaptive deterrents, but in modern trauma they become maladaptive because they push people to hide, self-punish, and avoid healing. Repetition compulsion is real and often appears as repeated abusive relationships or self-defeating behavior; it reflects an unconscious attempt to make the original trauma 'right.' Healing requires bringing trauma into words and awareness; talking, writing, and being witnessed by a non-recoiling other reduce its power. Short-term coping strategies can help a person function, but they often preserve the trauma problem rather than solve it. Good therapy depends primarily on rapport, flexibility, and the therapist's ability to adapt to the patient's needs rather than strict allegiance to one modality. Medication can be valuable for specific diagnoses and for increasing distress tolerance during therapy, but overprescribing often reflects system constraints rather than optimal care. Stimulants can help true ADHD, but when used without a real diagnosis they can worsen anxiety, impulsivity, vigilance, and even precipitate psychosis. Cannabis may help some people with sleep or narrowing attention, but it is not a universal treatment for anxiety, depression, or trauma. Psychedelics may help by reducing cortical chatter and enabling a deeper, more compassionate perspective on trauma, while MDMA may increase permissiveness and emotional access during guided trauma work.

Data Points: Overdose deaths in the U.S.: 100,000 per year - Conti cites this as an example of how trauma and addiction can lead to death at scale. Therapy frequency minimum: Once a week - Conti says less than weekly therapy often leads to too much catching up and less progress. Intensive therapy format: 30 clinical hours in one week - He describes intensive multi-clinician treatment as roughly equivalent to a year's worth of therapy consolidated. Typical intensive team size: 5 or 6 clinicians - Used in the example of a high-intensity treatment week. Medication use comparison: Approximately 5 times as much medicine - Conti says the U.S. uses far more medication than the Dutch population, reflecting system-level differences. Age reference: 24 years old - Conti describes his own trauma response after his younger brother died by suicide when he was in his early 20s. Age reference: 10-11 years old - Used in an example of a child abused and manipulated by an adult coach. College stimulant misuse: Upwards of 75% - Huberman references survey/discussion estimates that many college students use stimulants semi-regularly off prescription to study. Psychedelic policy timeline: Early 2023 - Conti references Oregon moving toward psilocybin legalization around this time.

Pivotal Quotes: "Trauma as not anything negative that happens to us, right? But something that overwhelms our coping skills and then leaves us different as we move forward." — Dr. Paul Conti: Core definition of trauma early in the conversation. "We so often try and change the trauma of the past in order to control the future." — Dr. Paul Conti: Explains the logic behind avoidance, repetition, and maladaptive coping. "It makes us feel better, but it doesn't make anything better." — Andrew Huberman: Summarizing the distinction between short-term relief and real healing.

Implications: Listeners are encouraged to treat trauma as a changeable brain-state problem, not a moral failing. The episode suggests that healing comes from curiosity, rapport, and targeted tools—therapy, self-reflection, and sometimes medication or psychedelics—used to address root causes rather than symptoms alone.

🔓 Sign Up for Unlimited Episode Search

About The Huberman Lab

The Huberman Lab podcast is hosted by Andrew Huberman, Ph.D., a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. The podcast discusses neuroscience and science-based tools, including how our brain and its connections with the organs of our body control our perceptions, our behaviors, and our health, as well as existing and emerging tools for measuring and changing how our nervous system works. Huberman has made numerous significant contributions to the fields of brain development, brain function, and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills, and cognitive functioning. He is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award, given to the scientist making the most significant discoveries in the study of vision, in 2017. Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets. In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.

View all episodes from The Huberman Lab